combined) assessment) of) high1sensitive) troponin) …€¦ ·  · 2015-05-21combined)...

25
1 Combined Assessment of High1Sensitive Troponin T and Non1invasive Coronary Plaque Composition for the Prediction of Cardiac Outcomes. Text word count (from Introduction to Discussion): 2651 ClinicalTrials.gov Identifier: NCT02030704 Gitsios Gitsioudis 1 , Alena Schüßler 1 , Eszter Nagy 1,2 , Pál Maurovich@Horvat 2 , Sebastian J. Buss 1 , Andreas Voss 3 , Waldemar Hosch 4 , Nina Hofmann 1 , Hans@Ulrich Kauczor 4 , Evangelos Giannitsis 1 , Hugo A. Katus 1 & Grigorios Korosoglou 1 . 1. University of Heidelberg, Department of Cardiology, Heidelberg, Germany. 2. MTA@SE Lendület Cardiovascular Imaging Research Group, Heart and Vascular Center, Semmelweis University, Budapest, Hungary. 3. University of Heidelberg, Institute of Psychology, Heidelberg, Germany 4. University of Heidelberg, Department of Diagnostic and Interventional Radiology, Heidelberg, Germany. Address for Correspondence: Grigorios Korosoglou, MD University of Heidelberg Department of Cardiology Im Neuenheimer Feld 410 Heidelberg, 69120, Germany !: [email protected] Tel: ++ 49 6221 56 4130 Fax: ++49 6221 56 5513 No support from any organisation for the submitted work Key words: atherosclerotic plaque composition, quantification analysis, 256@slice cardiac computed tomography, high sensitive troponin T.

Upload: ngohanh

Post on 01-Apr-2018

217 views

Category:

Documents


2 download

TRANSCRIPT

! 1!

Combined) Assessment) of) High1Sensitive) Troponin) T) and) Non1invasive)

Coronary)Plaque)Composition)for)the)Prediction)of)Cardiac)Outcomes.)

!!

!

Text)word)count)(from)Introduction)to)Discussion):)2651)

!

ClinicalTrials.gov)Identifier:)NCT02030704)

!

Gitsios!Gitsioudis1,!Alena!Schüßler1,!Eszter!Nagy1,2,!Pál!Maurovich@Horvat2,!Sebastian!J.!

Buss1,! Andreas! Voss3,! Waldemar! Hosch4,! Nina! Hofmann1,! Hans@Ulrich! Kauczor4,!

Evangelos!Giannitsis1,!Hugo!A.!Katus1!&!Grigorios!Korosoglou1.!

!

1.!!University!of!Heidelberg,!Department!of!Cardiology,!Heidelberg,!Germany.!

2.!MTA@SE!Lendület!Cardiovascular!Imaging!Research!Group,!Heart!and!Vascular!Center,!

Semmelweis!University,!Budapest,!Hungary.!

3.!University!of!Heidelberg,!Institute!of!Psychology,!Heidelberg,!Germany!!

4.! University! of! Heidelberg,! Department! of! Diagnostic! and! Interventional! Radiology,!

Heidelberg,!Germany.!

)Address!for!Correspondence:! Grigorios!Korosoglou,!MD!

University!of!Heidelberg!Department!of!Cardiology!!Im!Neuenheimer!Feld!410!Heidelberg,!69120,!Germany!

! ! ! ! ! !:[email protected]!! ! ! ! ! Tel:!++!49!6221!56!4130!! ! ! ! ! Fax:!++49!6221!56!5513!

No)support)from)any)organisation)for)the)submitted)work)

)

)

Key) words:! atherosclerotic! plaque! composition,! quantification! analysis,! 256@slice!

cardiac!computed!tomography,!high!sensitive!troponin!T.!

! 2!

Advances)in)Knowledge.)

" Cardiac! computed! tomography! angiography! (CCTA)@based! quantitative! coronary!

plaque!volume!is!associated!with!serum!levels!of!high@sensitive!Troponin!T!(hsTnT)!

(r=0.27,!95%[email protected],!p<0.0001).!

" The! presence! of! none! or! purely! calcified! versus! non@calcified! plaques! (HR=26.08,!

95%[email protected],! p=0.005),! plaque! volume! by! tertiles! (HR=12.14,! 95%CI=1.87@

78.74,! p=0.009),! and! increased! hsTnT! (≥14pg/ml)! (HR=10.31,! 95%[email protected],!

p=0.0006)! are! independent! predictors! of! outcome,! surpassing! the! value! of!

conventional!atherogenic!risk!factors!and!calcium!scoring.!

" Cardiac!events!mainly!occur!in!patients!with!simultaneously!elevated!plaque!volume!

and!hsTnT!values,! and! in! those!with!non@calcified! lesions! and! increased!hsTnT.! In!

contrast! to! hsTnT,! hsCRP! does! not! provide! complementary! value! to! CCTA! for! the!

prediction!of!future!myocardial!infarction!and!cardiac!death.!

)

Implications)for)Patient)Care.)

" The!presence!of!simultaneously!increased!plaque!burden!and!hsTnT!(>12pg/ml)!in!

patients!with! stable! CAD! indicates! a! potentially! unstable! cardiovascular! condition.!

Such!patients!may!be!future!candidates!for!more!aggressive!pharmacologic!therapy,!

with!hsTnT!serving!as!a!therapeutic!target.!

!

!

!

!

!

!

!

!

!

!

!

! 3!

Abstract)

Purpose.) To! determine! the! ability! of! plaque! volume! and! composition! assessment! by!

cardiac! computed! tomography! angiography! (CCTA)! and! high! sensitive! troponin! T!

(hsTnT)! for! the! risk! stratification! of! patients! at! intermediate! risk! for! coronary! artery!

disease!(CAD).!

Materials) and) Methods.) Our! study! complied! with! the! Declaration! of! Helsinki,! was!

approved!by!our!local!ethic!committee!and!all!patients!gave!written!informed!consent.!

521! consecutive! patients! (62±10! years,! 49%! male! gender)! were! included! in! our!

prospective!observational! longitudinal! single@center! study.!Quantitative!CCTA!analysis!

was! performed! in! all! patients! (n=7,690! coronary! segments),! whereas! biomarkers!

(hsTnT! &! hsCRP)! were! available! in! 408! patients! (78%).! To! evaluate! the! incremental!

value!of!CCTA!and!hsTnT!for!the!prediction!of!cardiovascular!events,!multivariate!Cox@

regression!and!integrated!discrimination!improvement!(IDI)!analysis!were!applied.!

Results.)In!521!patients,)13!hard!cardiac!events!occurred!during!a!2.3±1.1!year!follow@

up! period! (median! 2.4,! range! [email protected]),! while! 23! patients! underwent! late! coronary!

revascularization.! The! Duke! clinical! score! was! 51±30%,! indicating! intermediate! risk.!

The!presence!of!none!or!purely!calcified!versus!non@calcified!plaques,!plaque!volume!by!

tertiles! and! increased! hsTnT! (≥14pg/ml)! were! independently! associated! with! hard!

cardiac! events! (HR=26.08,! 95%[email protected];! HR=12.14,! 95%[email protected]! and!

HR=10.31,! 95%[email protected],! respectively,! p<0.01! for! all).! Patients!with! both! elevated!

hsTnT!and!plaque!burden!(n=53)!showed!the!highest!incidence!for!hard!cardiac!events!

(annual! rate=12.7%),! followed!by! those!with! either! elevated! hsTnT!or! plaque! burden!

(n=145;! annual! rate=0.44%,! p<0.03),! while! those! with! both! lower! hsTnT! and! plaque!

burden!exhibited!excellent!outcomes!and!no!hard!event!during!the! follow@up!duration!

(n=210;!annual!rate=0%,!p<0.001).!!

! 4!

Conclusion.! Using! hsTnT,! as! a! marker! of! myocardial! micro@injury,! and! CCTA,! as! a!

marker!of!the!total!atherosclerotic!burden,!improves!the!prediction!of!cardiac!outcome!

in! presumably! stable! CAD! patients,! and! may! aid! personalized! risk@stratification! in!

patients!at!intermediate!risk.!

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

!

! 5!

Introduction!

Rupture! of! ‘vulnerable’! atherosclerotic! lesions! with! subsequent! coronary! artery!

thrombosis!is!the!most!common!cause!of!myocardial!infarction!(MI)!and!sudden!cardiac!

death! (1).! Plaque! composition,! such! as! a! large! necrotic! core,! thin! fibrous! cap! and!

positive! artery! vessel! remodeling! are! indicators! of! plaque! vulnerability! and! cardiac!

events!in!patients!with!ischemic!heart!disease!(2,!3).!

Cardiac!computed!tomography!angiography!(CCTA)! is!a!well@established!technique!for!

visualization! of! both! coronary! lumen! narrowing! and! plaque! composition! (4,! 5).! Thus,!

several! CCTA! outcome! studies! have! assessed! plaque! burden! and! composition! in! both!

symptomatic!and!asymptomatic!patients!(6@8).!Cardiac!troponins!on!the!other!hand,!are!

sensitive!biomarkers!of!myocardial!injury!associated!with!death,!MI!and!heart!failure!in!

patients! with! chronic! ischemic! heart! disease! and! preserved! systolic! LV@function! (9).!

Although!elevations!of!cardiac!troponins!are!predictive!for!outcome!in!non@ACS!patients!

with!presumably!stable!CAD,!the!role!of!plaque!volume!and!composition!by!CCTA!on!the!

predictive!power!of!high!sensitive!troponin!T!(hsTnT)!has!not!been!investigated!so!far.!!

We! therefore! sought! to! determine! the! ability! of! plaque! volume! and! composition!

assessment! by! cardiac! computed! tomography! angiography! (CCTA)! and! high! sensitive!

troponin! T! (hsTnT)! for! the! risk! stratification! of! patients! at! intermediate! risk! for!

coronary!artery!disease!(CAD).!

!

!

!

!

!

!

!

! 6!

Materials)and)Methods)

Study) Population.) Our! observational! longitudinal! single@center! study! included!

prospectively!564!consecutive!patients!scheduled!for!CCTA!due!to!suspected!or!known!

coronary! artery! disease! (CAD)! between! February! 2008! and! April! 2012!

(www.clinicaltrials.gov,!HDCCTA01).!A! flow!chart!of!our!study! is!provided! in!Figure!1.!

Inclusion!and!exclusion!criteria!as!well!as!the!demographic!and!clinical!characteristics,!

which!were! recorded! in! our! patient! cohort,! are! provided! in! the! online! Appendix! and!

Suppl.!Table!1.!Our! study!complied!with! the!Declaration!of!Helsinki,!was!approved!by!

our!local!ethic!committee!and!all!patients!gave!written!informed!consent.!

Cardiac)CT)Imaging)and)Analysis.!All!imaging!was!performed!with!a!256@detector!row!

CT! scanner! (iCT,! Philips! Medical! Systems,! Best,! The! Netherlands)! with! a!

2x128x0.625mm!detector!configuration,!as!previously!described!(10).!Details! in! terms!

of! patient! preparation! and! CCTA! protocols! are! provided! in! the! online! Appendix.!

Coronary!CT!angiograms!were!analyzed!independently!by!two!experienced!readers!(G.G.!

&! S.B.)! both! with! >5! years! of! experience! in! coronary! CTA! equivalent! to! the! clinical!

competence! statement! training! level! 3! of! the! American! College! of! Cardiology!

Foundation/American!Heart!Association! (AHA)! (11).!The!methods!used! for!evaluation!

of! diagnostic! image! quality,! visual! plaque! evaluation! and! quantitative! assessment! of!

Agatston!score,!luminal!narrowing!and!coronary!plaque!volume!and!composition!using!

the! dedicated! software! (Extended! Brilliance!Workspace! 4.0,! Philips!Medical! Systems)!

have!been!described!previously!(details!provided!in!the!online!Appendix)!(5,!12).!!

Biomarkers.) Blood! samples!were! taken! before! the! CCTA! examination! for! hsCRP! and!

hsTnT!measurements.! A! detailed! description! of! biomarker! analysis! is! available! in! the!

online!Appendix.!

Follow1up) and) Study) Endpoints.! Personnel! unaware! of! the! CCTA! results! contacted!

each!subject!or!an! immediate! family!member.!Follow@up!evaluation!was!performed!by!

! 7!

A.S.!&!G.G..!The!most!important!portions!of!this!study!were!performed!and!reviewed!by!

G.G.!and!G.K.,!who!both!have!>5!years!experience! in!coronary!CTA!and!cardiovascular!

imaging.!

The!date!of! this!contact!was!used! for! the!calculation!of! the! follow@up!time!duration.!A!

standardized!questionnaire!was!used!to!collect!outcome!data!determined!from!patient!

interviews!at!the!outpatient!clinic!or!by!telephone!interviews.!Reported!clinical!events!

were! confirmed! by! review! of! the! corresponding! medical! records! in! our! electronic!

Hospital! Information! System,! and! contact! with! the! general! practitioner,! referring!

cardiologist,!or!the!treating!hospital.!!

The! primary! endpoints! were! cardiac! death! (sudden! death! due! to! arrhythmia,! fatal!

myocardial! infarction! or! intractable! heart! failure)! and! non@fatal! MI! (13).! Secondary!

endpoints! were! the! occurrence! of! clinically! indicated! revascularization! procedures! 3!

months!of!CCTA!by!percutaneous!coronary!intervention!(PCI)!or!coronary!artery!bypass!

graft!surgery!(CABG).!Early!revascularizations!with!less!than!3!months!of!CCTA!were!not!

considered,!because!CCTA!results!may!have!triggered!revascularization!procedures,!and!

these!patients!were!censored!at!the!time!of!early!revascularization!(n=23).!!!

Statistical)Analysis.)Categorical!variables!are!presented!as!number!(%)!and!continuous!

variables!as!mean!±!standard!deviation!(SD)!or!median!and!interquartile!range!(IQR),!as!

appropriate.! The! chi@square! test! was! used! for! comparison! of! categorical! variables.!

Comparisons!between!groups!were!made!using!either!the!independent@samples!t@test!or!

the!Mann@Whitney!U! test,! as! appropriate.! For!all! continuous!parameters!derived! from!

CCTA! analysis! and! biomarkers,! receiver! operating! characteristics! (ROC)! curves! were!

plotted! and! cut! off! values! were! determined! to! derive! the! optimal! trade@off! between!

sensitivity!and!specificity!for!each!parameter.!For!survival!analysis,!Kaplan@Meier!curves!

were!generated!to!estimate!the!distribution!of!cardiac!events!and!the!annual!event!rate!

as! a! function! of! the! follow@up! duration! using! categorical! or! ROC! optimized! values! for!

! 8!

quantitative! variables.! To! identify! predictors! of! cardiac! endpoints! we! performed! a!

successive! Cox! proportional@hazards! univariate! and! multivariate! analysis! with!

Bonferroni! adjustment! for! multiple! comparisons.! Integrated! Discrimination!

Improvement! (IDI)! values! were! calculated! using! the! ‘survIDINRI’! software! package.!

Power! of! Cox! regression! was! analyzed! using! the! ‘powerSurvEpi’! library! for! the! R!

software.! !Power! is!presented! for!a!Hazard!ratio!of!HR=2! for!a!variable!with!standard!

deviation! 1! (i.e.,! an! increase! of! 1! SD! is! assumed).! Intraobserver! and! interobserver!

variability! for! quantification! of! plaques! and! lumen! narrowing! were! calculated! by!

repeated!analysis!of!40!randomly!selected!CCTA!cases.!The!readings!were!separated!by!

8! weeks! to! minimize! recall! bias.! P<0.05! was! indicative! of! significant! difference.!

Statistical! analyses! were! performed! with! use! of! MedCalc! software! (MedCalc®! 13.2.0,!

Ostend,!Belgium)!by!G.K.!&!G.G..!A.V.!performed!IDI!analysis!and!power!calculation.!

)

Results!

Clinical) Characteristics) and) Outcomes.) Diagnostic! image! quality! was! achieved! in!

7,690! of! 7,815! (98.4%)! coronary! segments.! During! the! follow@up! period! (median! 2.4!

years,[email protected]!years),!13!hard!cardiac!events!occurred,!including!3!cardiac!deaths!

and!10!nonfatal! infarctions,!while!23!patients!underwent! late!revascularization!(17!by!

PCI! and! 6! by! CABG).! The! Duke! clinical! score! was! 51±30%! indicating! intermediate!

likelihood!for!CAD.!Significant!differences!were!observed!between!patients!with!(n=36)!

and!without!cardiac!events!(n=485)!in!terms!of!atherogenic!risk,!history!of!CAD,!serum!

creatinine,!hsTnT,!calcium!score!and!plaque!burden!and!stenosis!(Suppl.!Table!1).!

Association) of) Plaque) Volume) and) Stenosis) with) hsTnT.) Increasing! hsTnT! was!

observed!with! increasing!plaque!burden.!Patients!with!stenosis!<25%!exhibited! lower!

hsTnT!compared! to! those!with! stenosis!≥25%,!whereas!no!differences!were!observed!

with!further!lumen!narrowing!increase!(Suppl.!Figure!1a,!c).!Patients!within!the!highest!

! 9!

tertile! for! plaque! burden! and! intermediate! stenosis! (50@75%)! exhibited! the! highest!

rates!for!cardiac!events!of!83%!and!58%,!respectively!(Suppl.!Figure!1b,!d).!!

Uni1)and)Multivariable)Analysis.!For!the!prediction!of!the!combined!endpoint,!power!

was! 0.96! for! univariate! analyses! and! 0.90! for! multivariate! analyses! (assuming! a!

common! variance! of! R²=0.25! for! each! covariate! with! all! other! covariates).! For! the!

primary! endpoint,! power! is! reduced! to! 0.60! for! univariate! analyses! and! 0.48! for!

multivariate! analyses.! By! univariate! analysis! clinical! parameters,! hsTnT,! calcium!

scoring,! plaque! composition! and! volume! were! predictive! for! cardiac! events! (Suppl.!

Table!2).! By! multivariable! analysis! plaque! volume! and! stenosis! severity! both!

exhibited! independent! predictive! value! for! hard! cardiac! events.! Adding! hsTnT! to! this!

model,!the!latter!together!with!total!plaque!volume!provided!the!most!robust!prediction!

of!cardiac!events,!while!hsCRP!was!not!predictive!(Table!1).!!!

Subsection)Visual)Plaque)Characteristics.!Patients!with!no!or!purely!(n=334)!calcified!

plaque!exhibited!lower!event!rates!compared!to!those!with!non@calcified!plaque!(n=187)!

(Figure! 2A).! Especially! in! patients! with! hsTnT<14pg/ng,! patients! with! no! or! purely!

calcified!plaque!(n=227)!showed!excellent!outcome!without!any!hard!event!(Figure!2B),!

compared! to! those! with! non@calcified! plaques! (n=118).! A! representative! case! of! a!

patient!with! non@calcified! plaque! and! increased! hsTnT>14.0pg/ml! is! presented! in! the!

Suppl.!Figure!2.!

ROC)and)IDI)Analysis.)Accuracy!for!the!prediction!of!cardiac!events!by!AUC!was!higher!

for! hsTnT,! plaque! volume! and! calcium! score! compared! with! the! Duke! clinical! score!

(Duke! score@AUC=0.55,! 95%[email protected];! calcium! score@AUC=0.80,! 95%[email protected];!

hsTnT@AUC=0.80,! 95%[email protected]! and! plaque! volume@ACU=0.87,! 95%[email protected],!

p<0.05!for!all,!Figure!3A).!!!

Using!a!series!of!Cox!models,!each!variable! including!calcium!score,! lumen!narrowing,!

total!plaque!volume!and!hsTnT!offered! incremental! information! for! the!assessment!of!

! 10!

hard!cardiac!events.!Both!by!χ²!and!by!IDI,!hsTnT!offered!incremental!value!to!clinical!

and!CCTA!findings!(Figure!3B).)

Survival)Analysis.!Patients!with!non@calcified!plaque!composition!showed!significantly!

poorer!outcomes!than!those!without!or!with!purely!calcified!plaque!(Figure!2A),!even!in!

the! subgroup! with! hsTnT<14pg/ml! (Figure! 2B).! In! addition! hsTnT! and! total! plaque!

volume! clearly! discriminated! between! patients!with! and!without! hard! cardiac! events!

(Figure!2C@D),!exhibiting! independent!and!additive!value! (Figure!2E@F).!Thus,!patients!

with!both!high!hsTnT!and!plaque!volume!(n=53)!showed!the!highest!annual!event!rates!

(12.7%! for!hard!and!15.6%! for!all! cardiac!events),! followed!by! those!with!either!high!

hsTnT!or!plaque!volume!(n=145,!0.4%!for!hard!and!2.9%!for!all!cardiac!events),!while!

those!with!both!low!hsTnT!and!plaque!volume!exhibited!excellent!outcomes!(n=210,!0%!

for!hard!and!0.3%!for!all!cardiac!events).!!

Analysis) by) Tertiles.) Analysis! by! tertiles! is! provided! in! Suppl.! Figure! 3.! Significant!

differences!were!observed!between!patients!within! the! lower!versus! those!within! the!

upper! tertile! of! hsTnT! (Suppl.! Figure! 3A@B).! The! clinically! established! cut@off! value! of!

hsTnT=14.0! pg/ml! was! also! strongly! predictive! (Suppl.! Figure! 3C@D).! Similar! results!

were!obtained!for!plaque!volume!(Suppl.!Figure!3E@F).!Patients!within!the!lower!tertiles!

for!hsTnT!and!plaque!volume!exhibited!no!cardiac!events.!92%!of!hard!and!81%!of!all!

cardiac!events!on!the!other!hand!occurred!in!patients!within!the!mid!or!upper!tertile!for!

hsTnT!and!plaque!volume!(Table!2).!!!

Observer) Agreement) and) Variabilities) and) Time1spent.) Inter@! and! intra@observer!

variabilites! for! the!assessment!of!plaque!volume!and!stenosis!were!13%!and!7%,!and!

11%! and! 9%,! respectively.! Agreement! between! observers! for! the! differentiation! of!

calcified! (i.e.! calcified! and! partially! calcified)! and! non@calcified! plaques! was! 93%!

(κ=0.85).! Quantitative! assessment! required! a! mean! time! spent! of! 3.9±3.1! min! per!

patient.!

! 11!

Discussion)

The!present!study!demonstrates! the! incremental!value!of! the!combined!assessment!of!

hsTnT! and! CCTA! for! the! prediction! of! cardiac! outcome! in! patients!with! intermediate!

likelihood! for! CAD.! In! our! cohort,! plaque! volume! and! composition! as! well! as!

quantification!of! luminal!narrowing!assessed!by!CCTA!were! independent!predictors!of!

outcome.! In! addition,! hsTnT! increased! with! increasing! plaque! burden! but! not! with!

increasing! lumen! narrowing.! Cardiac! events! primarily! occurred! in! patients! with! high!

plaque! burden! (by! quantitative! analysis),! and! hsTnT! values! and! in! those! with! non@

calcified! lesions! (by! visual! analysis)! and! moderate! lumen! narrowing! (50@75%,! by!

stenosis!quantification).!In!contrast!to!hsCRP,!hsTnT!provided!complementary!value!to!

CCTA!for!the!prediction!of!future!myocardial!infarction!and!cardiac!death.!!

A!critical!coronary!obstruction! is!usually!associated!with!the!presence!of!symptomatic!

disease! (14).! Increasing! evidence! on! the! other! hand,! shows! that! plaque! morphology!

assessed!by!CCTA!adds!value!to!lumen!narrowing!for!the!prediction!of!cardiac!events!(6,!

8,! 15,! 16).! Quantitative! analysis! of! plaque! burden!was! also! recently! shown! to! predict!

future!acute!coronary!syndrome!in!patients!with!stable!CAD!(5).!Our!CCTA@based!plaque!

analysis! in!7,690! coronary! segments! confirmed! the!predictive! value!of! plaque!burden!

and!lumen!narrowing,!which!in!our!cohort!both!surpassed!the!value!of!conventional!risk!

factors!and!calcium!score.!Using!multivariate!analysis,!both!variables!were!independent!

predictors!for!cardiac!events.!Plaque!volume!was!linearly!related!to!increasing!rates!of!

cardiac! events,! which! is! in! agreement! with! previous! CCTA! studies! (5).!With! stenosis!

severity,!on!the!other!hand!rather!intermediate!(50@75%)!lesions,!which!may!have!been!

partially! judged! as! functionally! non@significant! by! FFR! subsequently! caused! hard!

endpoints!(3,!14,!17).!This!weaker!association!of!increasing!lumen!narrowing!with!hard!

events! is! in! line! with! the! results! of! the! FAME! 2! trial,! where! targeting! functional!

significant! lesions! reduced! the! subsequent! revascularization! rates! but! not! the! rate! of!

! 12!

‘hard!cardiac!events’,!such!as!infarction!and!cardiac!death!(18).!Calcium!scoring!on!the!

other!hand,!exhibited!significant!HR!for!the!prediction!of!hard!and!all!cardiac!events!by!

univariate!analysis,!which!is! in!agreement!with!previous!large!scale!clinical!trials!(19).!

However,!when!plaque!volume!was!also!considered!in!the!multivariable!model,!calcium!

scoring! was! no! longer! significant,! which! is! also! in! agreement! with! previous! studies,!

showing!that!CCTA!is!superior!to!calcium!scoring!for!the!estimation!of!cardiac!outcomes!

(20,!21).!

The! role! of! cardiac! troponins! for! the! assessment! of! cardiac! risk! both! in! stable! CAD!

patients! and! in! apparently! healthy! subjects!was! demonstrated! in! several! studies! (22,!

23).! This! association! could! be! confirmed! in! the! PEACE! study,! showing! that! cardiac!

troponins! measured! by! high! sensitivity! assays! are! independent! markers! of! cardiac!

outcomes! in! a! large! patient! cohort! (9).! In! our! study,! we! confirmed! this! association!

between!hsTnT!blood! levels!and!cardiac!outcomes.! In! line!with!previous!CCTA!studies!

we!also!demonstrated!a!correlation!between!hsTnT!and!CCTA@based!plaque!burden!(24,!

25).!Interestingly,!we!found!an!increase!of!hsTnT!with!increasing!plaque!burden!but!not!

with!increasing!lumen!narrowing.!In!this!regard,!increased!hsTnT!levels!in!the!absence!

of!flow!limiting!stenosis!but!in!the!presence!of!increased!plaque!burden,!indicates!severe!

myocardial! injury! or! irreversible! myocyte! death,! possibly! caused! by! silent! plaque!

rupture,! micro@embolization! and! microvascular! obstruction,! which! may! precede! the!

clinical!manifestation!of!MI!(26).!In!the!same!line,!a!recent!prospective!clinical!trial!could!

demonstrate!that!patients!with!presumably!stable!CAD!but!vulnerable!coronary!plaques!

by! 18F@fluoride! positron! emission! tomography,! had! higher! plasma! concentration! of!

cardiac! troponins,! compared! to! patients! without! such! unstable! plaques! (27).! These!

observations!are!in!agreement!with!earlier!angioscopy!studies,!identifying!silent!plaque!

rupture! in!~20%!of!patients!with!clinically!stable!CAD!(28).!As!plaque!burden!reflects!

the!anatomic!surrogate!of!potentially!critical!lesions!and!hsTnT!the!functional!surrogate!

! 13!

of! silent!plaque!rupture!causing!micronecrosis,! the!markedly! increased!cardiac!events!

rate! in! patients! with! increased! plaque! burden! and! hsTnT,! i.e.! in! those! who! combine!

these!2!potential!hazards!is!not!surprising.!Since!clinical!and!experimental!data!suggest!

that! systemic! response! to! ischemic! injury! or! micro@injury! may! aggravate! chronic!

atherosclerosis!(29),!hsTnT!may!represent!a!novel!therapeutic!target!for!the!primary!or!

secondary!prevention!of!CAD.!

CRP!was!initially!supposed!to!be!a!causal!player!for!atherosclerotic!plaque!development!

and!inflammation!(30).!However,!further!basic!science!research!has!questioned!a!direct!

atherogenic!mechanism!(31,!32).!Others!and!we!showed!previously!that!serum!levels!of!

hsCRP! are! only! weakly! correlated! with! plaque! composition! and! coronary! artery!

calcification!and!largely!determined!by!the!presence!of!risk!factors!(25,!33).!In!this!line,!

we! demonstrated! that! hsTnT! but! not! hsCRP! provide! complementary! value! to! CCTA@

based!plaque!volume!and!composition!for!the!prediction!of!future!myocardial!infarction!

and!cardiac!death.!)

Limitations.!The!number!of!cardiac!events!such!as!cardiac!death!and!MI!was!relatively!

small.! In! addition,!both! retrospective! and!prospective!ECG!gated!acquisition!protocols!

were!used!in!our!study,!so!that!we!cannot!surely!exclude!some!impact!of!the!scanning!

protocols! on! plaque! quantification! by! our! computer! assisted! algorithm.! No! perfusion!

analysis! was! performed.! HsTnT! and! hsCRP! data! were! available! in! only! ~80%! of! our!

patients,!while!HbA1c!was!available!in!the!minority!of!our!patients,!which!is!a!limitation.!

Despite,!the!high!isotropic!resolution!of!0.65mm!we!cannot!exclude!that!some!portion!of!

very!“flat”!coronary!plaques,!which!were!missed!by!quantitative!plaque!analysis.!Finally,!

multiple! other! conditions! for! elevated! hsTnT! serum! levels,! which! may! be! related! to!

other! non@coronary! reasons,! such! as! cardiomyopathy,! left! ventricular! hypertrophy,!

myocarditis!or!excessive!endurance!exercise!(34,!35),!cannot!be!completely!excluded!in!

our!patient!cohort.)

! 14!

Conclusion!

Our!study!demonstrates!the!complementary!value!of!hsTnT!and!quantitatively!assessed!

coronary! plaque! burden! for! the! prediction! of! cardiac! outcome! in! patients! with!

intermediate!likelihood!for!CAD.!This!approach!may!aid!personalized!risk@stratification!

in! patients! with! presumably! stable! CAD.! Since! all! techniques! used! herein! are! readily!

available! in! the! clinical! routine! and! are! associated!with! an! acceptable! time! spent! the!

translation!of!our!findings!to!the!clinical!realm!appears!promising.!

!

References)1.! Naghavi!M,!Libby!P,!Falk!E,!et!al.!From!vulnerable!plaque!to!vulnerable!patient:!a!call! for! new! definitions! and! risk! assessment! strategies:! Part! I.! Circulation.!2003;108(14):1664@72.!2.! Tanaka!A,!Kawarabayashi!T,!Nishibori!Y,!et!al.!No@reflow!phenomenon!and!lesion!morphology! in! patients! with! acute! myocardial! infarction.! Circulation.!2002;105(18):2148@52.!3.! Virmani! R,! Burke!AP,! Farb!A,! Kolodgie! FD.! Pathology! of! the! vulnerable! plaque.!Journal!of!the!American!College!of!Cardiology.!2006;47(8!Suppl):C13@8.!4.! Achenbach!S,!Moselewski!F,!Ropers!D,!et!al.!Detection!of!calcified!and!noncalcified!coronary! atherosclerotic! plaque! by! contrast@enhanced,! submillimeter! multidetector!spiral! computed! tomography:! a! segment@based! comparison! with! intravascular!ultrasound.!Circulation.!2004;109(1):14@7.!5.! Versteylen!MO,!Kietselaer!BL,!Dagnelie!PC,!et!al.!Additive!value!of!semiautomated!quantification! of! coronary! artery! disease! using! cardiac! computed! tomographic!angiography!to!predict!future!acute!coronary!syndrome.!Journal!of!the!American!College!of!Cardiology.!2013;61(22):2296@305.!6.! Andreini!D,!Pontone!G,!Mushtaq!S,!et!al.!A!long@term!prognostic!value!of!coronary!CT! angiography! in! suspected! coronary! artery! disease.! JACC! Cardiovascular! imaging.!2012;5(7):690@701.!7.! Motoyama! S,! Sarai! M,! Harigaya! H,! et! al.! Computed! tomographic! angiography!characteristics! of! atherosclerotic! plaques! subsequently! resulting! in! acute! coronary!syndrome.!Journal!of!the!American!College!of!Cardiology.!2009;54(1):49@57.!8.! Bamberg!F,!Sommer!WH,!Hoffmann!V,!et!al.!Meta@analysis!and!systematic!review!of!the!long@term!predictive!value!of!assessment!of!coronary!atherosclerosis!by!contrast@enhanced!coronary!computed!tomography!angiography.!Journal!of!the!American!College!of!Cardiology.!2011;57(24):2426@36.!9.! Omland!T,!Pfeffer!MA,!Solomon!SD,!et!al.!Prognostic!value!of! cardiac! troponin! I!measured!with!a!highly!sensitive!assay!in!patients!with!stable!coronary!artery!disease.!Journal!of!the!American!College!of!Cardiology.!2013;61(12):1240@9.!10.! Gitsioudis!G,!Hosch!W,! Iwan! J,! et! al.!When!do!we! really! need! coronary! calcium!scoring! prior! to! contrast@enhanced! coronary! computed! tomography! angiography?!Analysis!by!age,!gender!and!coronary!risk!factors.!PloS!one.!2014;9(4):e92396.!

! 15!

11.! Budoff!MJ,!Cohen!MC,!Garcia!MJ,!et!al.!ACCF/AHA!clinical!competence!statement!on!cardiac!imaging!with!computed!tomography!and!magnetic!resonance:!a!report!of!the!American! College! of! Cardiology! Foundation/American! Heart! Association/American!College! of! Physicians! Task! Force! on! Clinical! Competence! and! Training.! Journal! of! the!American!College!of!Cardiology.!2005;46(2):383@402.!12.! Korosoglou! G,! Mueller! D,! Lehrke! S,! et! al.! Quantitative! assessment! of! stenosis!severity!and!atherosclerotic!plaque!composition!using!256@slice!computed!tomography.!European!radiology.!2010;20(8):1841@50.!13.! Antman! EM,! Anbe! DT,! Armstrong! PW,! et! al.! ACC/AHA! guidelines! for! the!management! of! patients! with! ST@elevation! myocardial! infarction;! A! report! of! the!American! College! of! Cardiology/American! Heart! Association! Task! Force! on! Practice!Guidelines! (Committee! to!Revise! the! 1999!Guidelines! for! the!Management! of! patients!with! acute! myocardial! infarction).! Journal! of! the! American! College! of! Cardiology.!2004;44(3):E1@E211.!14.! Narula!J,!Strauss!HW.!The!popcorn!plaques.!Nature!medicine.!2007;13(5):532@4.!15.! Min! JK,! Dunning! A,! Lin! FY,! et! al.! Age@! and! sex@related! differences! in! all@cause!mortality! risk! based! on! coronary! computed! tomography! angiography! findings! results!from!the!International!Multicenter!CONFIRM!(Coronary!CT!Angiography!Evaluation!for!Clinical! Outcomes:! An! International! Multicenter! Registry)! of! 23,854! patients! without!known! coronary! artery! disease.! Journal! of! the! American! College! of! Cardiology.!2011;58(8):849@60.!16.! Puchner!SB,!Liu!T,!Mayrhofer!T,!et!al.!High@Risk!Plaque!Detected!on!Coronary!CT!Angiography!Predicts!Acute!Coronary!Syndromes!Independent!of!Significant!Stenosis!in!Acute!Chest!Pain:!Results!From!the!ROMICAT@II!Trial.!Journal!of!the!American!College!of!Cardiology.!2014;64(7):684@92.!17.! Arbustini!E,!Grasso!M,!Diegoli!M,!et!al.!Coronary!atherosclerotic!plaques!with!and!without!thrombus! in! ischemic!heart!syndromes:!a!morphologic,! immunohistochemical,!and!biochemical!study.!The!American!journal!of!cardiology.!1991;68(7):36B@50B.!18.! De!Bruyne!B,!Pijls!NH,!Kalesan!B,!et!al.!Fractional!flow!reserve@guided!PCI!versus!medical! therapy! in! stable! coronary! disease.! The! New! England! journal! of! medicine.!2012;367(11):991@1001.!19.! Pletcher!MJ,!Tice!JA,!Pignone!M,!Browner!WS.!Using!the!coronary!artery!calcium!score!to!predict!coronary!heart!disease!events:!a!systematic!review!and!meta@analysis.!Arch!Intern!Med.!2004;164(12):1285@92.!20.! Hadamitzky!M,!Distler!R,!Meyer!T,!et!al.!Prognostic!value!of!coronary!computed!tomographic! angiography! in! comparison!with! calcium!scoring! and! clinical! risk! scores.!Circulation!Cardiovascular!imaging.!2011;4(1):16@23.!21.! Hou! ZH,! Lu! B,! Gao! Y,! et! al.! Prognostic! value! of! coronary! CT! angiography! and!calcium! score! for! major! adverse! cardiac! events! in! outpatients.! JACC! Cardiovascular!imaging.!2012;5(10):990@9.!22.! Wallace! TW,! Abdullah! SM,! Drazner! MH,! et! al.! Prevalence! and! determinants! of!troponin!T!elevation!in!the!general!population.!Circulation.!2006;113(16):1958@65.!23.! Zethelius! B,! Johnston! N,! Venge! P.! Troponin! I! as! a! predictor! of! coronary! heart!disease!and!mortality!in!70@year@old!men:!a!community@based!cohort!study.!Circulation.!2006;113(8):1071@8.!24.! Laufer!EM,!Mingels!AM,!Winkens!MH,!et!al.!The!extent!of!coronary!atherosclerosis!is! associated! with! increasing! circulating! levels! of! high! sensitive! cardiac! troponin! T.!Arteriosclerosis,!thrombosis,!and!vascular!biology.!2010;30(6):1269@75.!25.! Korosoglou! G,! Lehrke! S,! Mueller! D,! et! al.! Determinants! of! troponin! release! in!patients! with! stable! coronary! artery! disease:! insights! from! CT! angiography!characteristics!of!atherosclerotic!plaque.!Heart.!2011;97(10):823@31.!

! 16!

26.! Heusch! G,! Schulz! R,! Haude!M,! Erbel! R.! Coronary!microembolization.! Journal! of!molecular!and!cellular!cardiology.!2004;37(1):23@31.!27.! Joshi! NV,! Vesey! AT,! Williams! MC,! et! al.! 18F@fluoride! positron! emission!tomography! for! identification! of! ruptured! and! high@risk! coronary! atherosclerotic!plaques:!a!prospective!clinical!trial.!Lancet.!2014;383(9918):705@13.!28.! de!Feyter!PJ,!Ozaki!Y,!Baptista! J,! et! al.! Ischemia@related! lesion!characteristics! in!patients! with! stable! or! unstable! angina.! A! study! with! intracoronary! angioscopy! and!ultrasound.!Circulation.!1995;92(6):1408@13.!29.! Dutta!P,!Courties!G,!Wei!Y,!et!al.!Myocardial!infarction!accelerates!atherosclerosis.!Nature.!2012;487(7407):325@9.!30.! Zhang!YX,!Cliff!WJ,!Schoefl!GI,!Higgins!G.!Coronary!C@reactive!protein!distribution:!its!relation!to!development!of!atherosclerosis.!Atherosclerosis.!1999;145(2):375@9.!31.! Clapp!BR,!Hirschfield!GM,!Storry!C,!et!al.!Inflammation!and!endothelial!function:!direct! vascular! effects! of! human! C@reactive! protein! on! nitric! oxide! bioavailability.!Circulation.!2005;111(12):1530@6.!32.! Koike! T,! Kitajima! S,! Yu! Y,! et! al.! Human! C@reactive! protein! does! not! promote!atherosclerosis!in!transgenic!rabbits.!Circulation.!2009;120(21):2088@94.!33.! Blaha!MJ,!Rivera!JJ,!Budoff!MJ,!et!al.!Association!between!obesity,!high@sensitivity!C@reactive!protein!>/=2!mg/L,!and!subclinical!atherosclerosis:! implications!of! JUPITER!from! the! Multi@Ethnic! Study! of! Atherosclerosis.! Arteriosclerosis,! thrombosis,! and!vascular!biology.!2011;31(6):1430@8.!34.! Shave!R,!Baggish!A,!George!K,!et!al.!Exercise@induced!cardiac!troponin!elevation:!evidence,!mechanisms,!and!implications.!Journal!of!the!American!College!of!Cardiology.!2010;56(3):169@76.!35.! Giannitsis! E,! Katus! HA.! Cardiac! troponin! level! elevations! not! related! to! acute!coronary!syndromes.!Nature!reviews!Cardiology.!2013.!!!!!!!!!!!!!!!!!!!!!!!!!

! 17!

Table) 1.) Multivariate! value! of! clinical,! laboratory! and! CCTA! data! for! the! prediction! of! hard!cardiac!events!and!revascularization!procedures.!

) Prediction) of) hard) cardiac)events) Prediction)of)all)cardiac)events!

Parameters) p1value) Hazard)ratios)

95%)Confidence)interval)

p1value) Hazard)ratios)

95%)Confidence)interval)

! Model)A:)Clinical)and)CCTA)data)

Total! number! of! risk! factors!(range!0@7)! NS! 0.50! 0.31 - 1.05! NS! 0.94! 0.67 - 1.32!

MDRD!(ml/min/1.73m2)! NS! 1.03! 0.99 - 1.06! NS! 0.99! 0.98 - 1.01!

Calcium!score!(Agatston!Units)! NS! 1.00! 0.99 - 1.00! NS! 1.00! 0.99 – 1.00!

Plaque)volume)by)tertiles)) 0.006) 17.95! 2.36 - 134.5! 0.003) 2.98! 1.44 – 6.18!

Lumen)narrowing)>)70%) 0.01) 5.50! 1.53 - 19.8! 0.0001) 4.32! 2.06 - 9.07!

! Model)B:)Clinical)data,)biomarkers)and)plaque)volume)by)CCTA)

Total!risk!factors!(range!0@7)! 0.008) 0.43! 0.23 - 0.80! NS! 0.92! 0.66!–!1.29!

MDRD!(ml/min/1.73m2)! NS! 1.00! 0.97!–!1.03! NS! 1.00! 0.98!–!1.02!

HsCRP!(mg/l)! NS! 0.98! 0.86!–!1.12! NS! 0.95! 0.87!–!1.05!

Normal) versus) increased)hsTnT)(<)vs.)≥14)pg/ml)) 0.0008) 10.26! 2.64!–!39.94! 0.036) 2.25! 1.06!–!4.78!

Plaque)volume)by)tertiles) 0.009) 12.14! 1.87!–!78.74! <0.0001) 4.78! 2.27!–!10.04!

! Model)C:)Clinical)data,)biomarkers)and)plaque)composition)

Total!risk!factors!(range!0@7)! 0.016) 0.44! 0.23!–!0.85! NS! 1.00! 0.72!–!1.39!

MDRD!(ml/min/1.73m2)! NS! 1.00! 0.97!–!1.03! NS! 1.00! 0.98!–!1.01!

HsCRP!(mg/l)! NS! 0.99! 0.88!–!1.12! NS! 0.96! 0.87!–!1.05!

Normal) versus) increased)hsTnT)(<)vs.)≥14)pg/ml)) 0.0006) 10.31! 2.72!–!39.00! 0.022) 1.05! 1.01!–!1.09!

None)or)purely)calcified)versus)non1calcified)plaques) 0.0045) 26.08! 2.78–244.99! 0.0002) 6.17! 2.41!–!15.77!

Data!are!presented!as!mean±SD!or!as!number!of!patients!and!corresponding!percentages.!HsTnT!and! hsCRP! indicate! high! sensitive! troponin! T! and! C@reactive! protein,! respectively,! and!MDRD!Modification! of! Diet! in! Renal! Disease.! Atherogenic! risk! factors! include! arterial! hypertension,!hyperlipidemia,!diabetes!mellitus,! advanced!age! (>65yrs.),! cigarette@smoking,! family!history!of!CAD,!overweight.!!!!!!!!!!!!!!!

! 18!

!Table)2.)Hard!and!all!cardiac!events!as!a!function!of!hsTnT!and!total!plaque!volume!tertiles.!!

! Hard% cardiac%events%

All% cardiac%events%

% HsTnT)tertiles)

HsTnT%lower%tertile%(3.063.5pg/ml)% 1!(8%)! 6!(17%)!

HsTnT%mid%tertile%(3.668.9pg/ml)% 2!(15%)! 11!(30%)!

HsTnT%upper%tertile%(9.0641.0pg/ml)% 10!(77%)! 19!(53%)!

% Plaque)volume)tertiles)

Plaque%volume%lower%tertile%(0.7632.9%mm3)% 0!(0%)! 1!(3%)!

Plaque%volume%mid%tertile%(33.0686.9%mm3)% 1!(8%)! 5!(14%)!

Plaque%volume%upper%tertile%(87.06331.2%mm3)% 12!(92%)! 30!(83%)!

% Lower) and) upper) tertiles) for)plaque)volume)&)HsTnT)

HsTnT%&%Plaque%volume%lower%tertiles;%N=70%(17%)% 0)(0%)) 0)(0%))

HsTnT% low% tertile%&Plaque%vol.%mid%&%upper% tertiles%or%vice%versa%N=142%(35%)% 1!(8%)! 7!(19%)!

HsTnT%&%Plaque%vol.%mid%&%upper%tertiles;%N=196%(48%)% 12)(92%)) 29)(81%))

!

!

!

!

! 19!

Figure)Captions.)Figure)1.)Flowchart.)521!patients!with!complete!CCTA!and!follow@up!data,!who!consisted!our!study!population.!Figure) 2.) Survival) analysis.) Patients!with! no! or! purely! calcified! plaque! exhibited! preferable!

outcome!compared!to!those!with!non@calcified!plaque!(A).!Especially!patients!with!no!or!purely!calcified! plaque! and! hsTnT<14! pg/ml! showed! no! hard! cardiac! events! (B).! Increased! hsTnT!plasma!concentration!or!plaque!burden!were!both!associated!with!a!higher!rate!of!hard!cardiac!events!(C@D).!Patients!with!both!increased!hsTnT!and!plaque!burden!exhibited!the!highest!rates!

for!hard!and!all!cardiac!events,!followed!by!those!with!either!increased!hsTnT!or!plaque!burden,!whereas!those!with!both!low!hsTnT!and!plaque!burden!demonstrated!excellent!outcome!(E@F).!Cumulative!event!rates!are!also!provided.!(#):!ROC!optimized!values).!Figure)3.)A:)ROC!analysis!for!Calcium!score,!hsTnT!(high@sensitive!Troponin!T),!plaque!volume!and!Duke! clinical! score! to! evaluate! the! accuracy! for! the! prediction! of! hard! cardiac! events.!B:!

Total) χ²) and) IDI) values.) In! a! series! of! Cox! models! and! starting! with! conventional! clinical!

markers! (atherogenic! risk! score! and! Modified! Diet! in! Renal! Disease! (MDRD)),! coronary!

calcification,! lumen! narrowing! and! quantitatively! assessed! plaque! burden! all! provided!

incremental!value! for! the!prediction!of!hard!cardiac!events.!Both!by!χ²!and!by! IDI! (Integrated!

Discrimination!Improvement),!hsTnT!offered!incremental!value!to!clinical!and!CCTA!findings!for!the!prediction!of!outcomes.!!!Supplementary) Figure) 1.) Association) of) hsTnT) with) plaque) burden) and) stenosis.)

Increasing!hsTnT!was!observed!with!increasing!plaque!burden.!Patients!with!stenosis<25%!on!

the! other! hand,! exhibited! lower! hsTnT! compared! to! those! with! stenosis≥25%,! whereas! no!

differences!were!observed!with! further! increasing! lumen!narrowing! (a,! c).!Patients!within! the!

highest! tertile! for! plaque! burden! and! intermediate! stenosis! (50%@75%)! exhibited! the! highest!

rates! for! cardiac! events! of! 83%! and! 58%,! respectively! (b,! d).! Values! are! shown! as!

mean±standard!deviation.)!

Supplementary) Figure) 2.) Patient) case.)This! example! shows! a! case! of! a!male!patient!with! a!

partially! calcified! and! a! non@calcified! lesion! in! the! first! diagonal! branch! and! circumflex! artery!

(red! and! blue! arrows! in! A),! respectively! both! resulting! to! moderate! lumen! narrowing.! His!

baseline! hsTnT!was! 18! pg/ml.! Stress@echocardiography!was! initially! performed!with! negative!

results.!10!months!later!this!patient!presented!in!with!non@ST!elevation!MI!(B),!presumably!due!

to!plaque!rupture!at!both!sites.!!He!then!received!PCI!and!stent!placement!in!both!lesions!(red!&!

blue! arrows)! (C).! CCTA! =! Coronary! CT@Angiography,! NSTEMI! =! non@ST! elevation! myocardial!

infarction,!LCX!=!left!circumflex!artery.!

Supplementary) Figure) 3.) Survival) analysis) by) tertiles.) Rates! for! hard! and! for! all! cardiac!

events!were!markedly!different!between!patients!with!hsTnT!(A@B)!and!plaque!volume!values!

(E@F)! within! the! lower! (hsTnT<3! to! 3.6! pg/ml)! versus! the! upper! tertiles! (hsTnT! 9.0! to! 41.0!

! 20!

pg/ml)! for! both! variables;! markedly! different! rates! for! cardiac! events! with! high! HR! and! χ²!

values!were!also!observed!using!the!predefined!upper!reference!limit!of!14.0pg/ml!(C@D).!

!

Supplementary,Tables.,Supplementary,Table,1.,Demographic,-laboratory-and-cardiac-CT-findings-in-patients-with-and-without-cardiac-events.-

Parameters, All,Patients,,,(n=521),

Patients,w/o,cardiac,events,(n=485),

Patients,with,hard,events,,,(n=13),

Patients,with,late,revasc.,,,(n=23)!

P#values!

- Clinical!data! -Age- 62±10- 62±10- 63±13- 62±10- NS-1.-Advanced-age->-65yrs.- 215-(42%)- 199-(41%)- 6-(46%)- 10-(43%)- NS-2.-Male-gender;-n-(%)- 256-(49%)- 230-(47%)- 10-(77%)- 16-(70%)- 0.02-3.-Arterial-hypertension! 398-(78%)- 364-(75%)- 12-(92%)- 22-(96%)- 0.03-4.-Hyperlipidemia! 330-(64%)- 303-(62%)- 6-(46%)- 21-(91%)- 0.008-5.-Smoking! 139-(27%)- 130-(27%)- 4-(31%)- 5-(22%)- NS-6.-Diabetes-mellitus! 59-(12%)- 51-(11%)- 0-(0%)- 8-(35%)- 0.001-7.-Family-history-of-CAD- 173-(34%)- 160-(33%)- 3-(23%)- 10-(43%)- NS-Sum-of-risk-factors-(0S7)- 3.0-±-1.3- 3.0-±-1.3- 3.2-±-0.8- 4.0-±-1.1- 0.001-Body-mass-index-(kg/m²)- 27.3-±-4.7- 27.2-±-4.7- 28.2-±-6.0- 28.5-±-4.7- NS-Typical-angina- 26-(5%)- 20-(4%)- 2-(15%)- 4-(17%)- 0.004-Atypical-angina- 104-(20%)- 100-(21%)- 1-(8%)- 3-(13%)- NS-Duke-clinical-score-(%)- 51-±-30- 51-±-31*- 49-±-26- 64-±-24- NS-History-of-CAD- 98-(19%)- 79-(16%)- 7-(54%)- 12-(52%)- <0.001-

! Laboratory!data!&!biomarkers! -Serum-creatinine-(mg/dl)- 0.90-±-0.22- 0.89-±-0.22- 0.94-±-0.29- 1.02-±-0.27- 0.01-Serum-urea-(mg/dl)- 35.0-±-10.6- 34.7-±-10.2- 40.8-±-18.9- 38.2-±-9.2- 0.05-MDRD-(ml/min/1.73m2)- 83.5-±-20.6- 83.7-±-20.4- 87.7-±-27.5- 77.1-±-19.9- NS-HsSCRP-(mg/l)- 4.2-±-4.5- 4.2-±-4.7- 4.9-±-2.7- 2.8-±-1.4- NS-HsSTnT-(pg/ml)- 8.6-±-7.1- 8.1-±-6.6- 18.6-±-11.2- 9.9-±-8.4- <0.001-

- Cardiac!computed!tomography!data! -Calcium-score-(Agatston-Units)-

115-±-207- 99-±-184- 267-±-170- 363-±-406- <0.001-

CAD-(any-plaque-or-stenosis)- 250-(49%)- 215-(44%)- 13-(100%)- 22-(97%)- <0.001-Max.-lumen-narrowing-(%)- 28-±-29- 25-±-28- 64-±-15- 65-±-17- <0.001-Lumen-narrowing->-50%- 162-(32%)- 130-(27%)- 12-(92%)- 20-(87%)- <0.001-Lumen-narrowing->-70%- 45-(9%)- 27-(6%)- 5-(38%)- 13-(57%)- <0.001-Plaques-per-patient- 1.2-±-1.8- 1.1-±-1.7- 3.1-±-1.7- 2.8-±-1.9- <0.001-Quantitative-plaque-volume-(mm³)-

39-±-65- 34-±-61- 141-±-79- 90-±-74- <0.001-

- Cardiac!medications! -ßSblockers! 264-(51%)- 235-(48%)- 10-(77%)- 19-(83%)- 0.001-ACE-inhibitors/AT-II-blockers!

274-(53%)- 250-(52%)- 6-(46%)- 18-(78%)- 0.04-Aspirin-or-Clopidogrel! 236-(45%)- 209-(43%)- 6-(46%)- 21-(91%)- <0.001-Coumadin! 42-(8%)- 44-(9%)- 2-(15%)- 3-(13%)- NS-Diuretics! 138-(26%)- 126-(26%)- 5-(38%)- 7-(30%)- NS-Statins- 232-(45%)- 204-(42%)- 6-(46%)- 22-(96%)- <0.001-Calcium-antagonists- 89-(7%)- 77-(16%)- 3-(23%)- 9-(39%)- 0.01-Data-are-presented-as-mean±standard-deviation-or-as-proportions.-hsSTnT-and-hsSCRP-indicate,-high- sensitive- troponin- T- and- CSreactive- protein,- respectively;- ACE- indicates- angiotensinSconverting- enzyme;-max.,-maximal;- AT,- angiotensin;- and-MDRD,-Modification- of- Diet- in- Renal-Disease.-(*,-p=0.04-versus-patients-without-events-for-the-Duke-Clinical-score).-

Supplementary, Table, 2., Univariate- value- of- clinical- laboratory- and- CCTA- data- for- the-prediction-of-hard-cardiac-events-and-revascularization-procedures.-, Prediction,of,hard,cardiac,

events, Prediction,of,all,cardiac,events!

Parameters, pEvalue, Hazard,ratios,

95%,Confidence,intervals,

pEvalue, Hazard,ratios,

95%,Confidence,intervals,

- Clinical,variables,Age- NS- 1.00- 0.95 - 1.06- NS- 1.00- 0.97 - 1.04-Male-gender;-n-(%)- 0.07- 3.20- 0.88 - 11.6- 0.004- 2.88- 1.39 - 5.95-Arterial-hypertension! NS- 3.31- 0.43 - 25.3- 0.02- 5.32- 1.28 - 21.9-Hyperlipidemia! 0.08- 0.37- 0.12 - 1.14- NS- 1.66- 0.78 - 3.52-Smoking! NS- 1.22- 0.37 - 3.95- NS- 0.99- 0.46 - 2.09-Diabetes-mellitus! NS- 0.00- 0.0 - 330222- 0.03- 2.41- 1.10 - 5.27-Family-history- NS- 0.51- 0.14 - 1.87- NS- 1.06- 0.53 - 2.08-Total-risk-factors-(range-0S7)- NS- 1.17- 0.72 - 1.90- 0.001- 1.54- 1.18 - 2.00-

History-of-coronary-artery-disease- 0.02- 3.69- 1.20 - 11.4- <0.0001- 4.54- 2.35-–-8.74-

- Biomarkers,&,Calcium,score,Serum-creatinine-(mg/dl)- NS- 1.65- 0.25 - 10.7- 0.003- 5.25- 1.74 - 15.8-Serum-urea-(mg/dl)- 0.06- 1.04- 0.99 - 1.09- 0.01- 1.03- 1.01 - 1.06-MDRD-(ml/min/1.73m2)- NS- 1.00- 0.98 - 1.03- NS- 0.99- 0.97 - 1.00-HsSCRP-(mg/l)- NS- 1.03- 0.93 - 1.15- NS- 0.98- 0.90 - 1.06-HsSTnT-(pg/ml)- <0.0001- 1.12- 1.07 - 1.17- <0.0001- 1.07- 1.04 - 1.10-HsSTnT-by-tertiles- 0.0086- 3.43- 1.37-–-8.57- 0.0076- 1.76- 1.17-–-2.67-Calcium-score-(Agatston-Units)- 0.005- 1.00- 1.00 - 1.00- <0.0001- 1.00- 1.00 - 1.01-

- CCTA:,Number,of,plaques,&plaque,composition,Total-number-of-plaques-- 0.0003- 1.45- 1.18 - 1.77- <0.0001- 1.41- 1.26 - 1.59-Presence-of-nonScalcified-plaques- <0.003- 22.2- 2.90 - 169.2- <0.0001- 23.5- 3.39 - 17.6-

Number-of-nonScalcified-plaques-(calcium-content<20%)-

<0.02- 1.97- 1.22 - 3.52- 0.05- 1.6- 1.00 - 2.41-

Number-of-partially-calcified-plaques-(calcium-content-20S80%)-

<0.001- 2.27- 1.53-S-3.37- <0.001- 1.92- 1.48-S-2.48-

Number-of-calcified-plaques-(calcium-content->80%)-

0.03- 1.38- 1.04-S-1.85- <0.001- 1.43- 1.20-S-1.68-

- CCTA:,Plaque,volume,&,lumen,narrowing-Plaque-volume-(mm³)- <0.0001- 1.01- 1.00 - 1.01- <0.0001- 1.01- 1.00-- 1.01-Plaque-volume-by-increments-of-10mm³- <0.0001- 1.19- 1.11-S-1.28- <0.0001- 1.14- 1.09-S-1.19-

Plaque-volume-by-tertiles- 0.009- 11.9- 1.87-S-75.70- <0.0001- 5.21- 2.67-S-10.1-Maximal-lumen-narrowing-(0S100%)- 0.0004- 1.05- 1.02 - 1.09- <0.0001- 1.07- 1.05 - 1.09-

Lumen-narrowing->-50%- 0.0006- 7.30- 2.37 - 22.4- <0.0001- 17.3- 8.9 - 33.7-Lumen-narrowing->-70%- 0.002- 24.50- 3.20 - 187.4- <0.0001- 20.4- 7.2 - 57.4-Single-versus-multiSvessel-CAD- 0.0002- 17.57- 3.9-S-78.9- <0.0001- 6.54- 3.28-S-13.1-

Data-are-presented-as-mean±standard-deviation-or-as-number-of-patients-and-corresponding-percentages.-HsTnT-and-hsCRP-indicate-high-sensitive-troponin-T-and-CSreactive-protein,-respectively,-and-MDRD-Modification-of-Diet-in-Renal-Disease.

Figure'1.'

'''Figure'2.'

!!!

Figure'3.'

!!Supp.'Fig.1.'

!!

Suppl.'Fig.'2.'

!!!Suppl.'Fig.3.'

'